Document is current
Any future updates will be listed below
-
Authors
Pollastri, Francesco https://orcid.org/0009-0006-1691-2196
Fassio, Angelo
Ferraro, Pietro Manuel
Andreola, Stefano
Gambaro, Giovanni
Spasiano, Andrea
Caletti, Chiara
Stefani, Lisa
Gatti, Matteo
Fabbrini, Paolo
Rossini, Maurizio
Galvagni, Isotta
Gatti, Davide
Adami, Giovanni
Viapiana, Ombretta
-
Funding
Funding for this research was provided by:
Università degli Studi di Verona
- License Information
-
More Information
Article History
Received: 13 November 2024
Accepted: 30 January 2025
First Online: 21 February 2025
Declarations
:
: DG has received advisory board honoraria, consultancy fees, and/or speaker fees from Amgen, Celgene, Eli-Lilly, MSD-Italia, Organon, and UCB. MR has received advisory board honoraria, consultancy fees and/or speaker fees from Abbvie, Eli-Lilly, Italfarmaco, Neopharmed-Gentili, Theramex, and UCB. GG has received speaker and advisory board honoraria from Vifor Pharma. PMF received consultant fees and grant/other support from Allena Pharmaceuticals, Alnylam, Amgen, AstraZeneca, Bayer, BioHealth Italia, Gilead, Novo Nordisk, Otsuka Pharmaceuticals, Rocchetta, and Vifor Fresenius and royalties as an author for UpToDate. All other authors declare no conflict of interest.
: The study was conducted within the protocol 1483CESC approved by our local Ethics Committee, in accordance with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The clinical and research activities being reported are consistent with the Principles of the Declaration of Istanbul as outlined in the “Declaration of Istanbul on Organ Trafficking and Transplant Tourism.” Written informed consent was obtained from all participants included.
